Allergy and immunology


Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine


Emergency medicine




Evidence-based medicine



Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics



Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine



Organisation of health care

Otolaryngology / head and neck surgery


Palliative care


Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy


Public health

Quality of care


Rehabilitation medicine

Renal medicine

Respiratory medicine


Sexual medicine

Sports medicine

Statistics and research methods



Travel medicine


Ops! No article found. Reset filter

Research projects in human genetics in Switzerland: analysis of research protocols submitted to cantonal ethics committees in 2018

Original article
Driessen S, Gervasoni P
Swiss Med Wkly. 2021;151:w20403

This analysis provides a full national overview of genetic research dossiers pertaining to clinical and nonclinical trials, and to further-use research projects submitted for approval to ethics committees in Switzerland in 2018 .

Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis

Review article: Medical guidelines
Schwotzer R, Flammer AJ, Gerull S, Pabst T, Arosio P, Averaimo M, Bacher VU, Bode P, Cavalli A, Concoluci A, Dirnhofer S, Djerbi N, Dobner SW, Fehr T, Garofalo M, Gaspert A, Heimgartner R, Hübers A, Jung HH, Kessler C, Knöpfel R, Laptseva N, Manka R, Mazzucchelli L, Meyer M, Mihaylova V, Monney P, Mylonas A, Nkoulou R, Pazhenkottil A, Pfister O, Rüfer A, Schmidt A, Seeger H, Stämpfli SF, Stirnimann G, Suter T, Théaudin M, Treglia G, Tzankov A, Vetter F, Zweier M, Gerber B
Swiss Med Wkly. 2020;150:w20364

These are the Swiss Amyloidosis Network recommendations which focus on diagnostic work-up and treatment of AL-amyloidosis. One aim of this meeting was to establish a consensus guideline regarding the diagnostic work-up and the treatment recommendations for systemic amyloidosis tailored to the Swiss health care system.

Concordance of tumour characteristics and survival clustering among pairs of first-degree relatives with breast cancer

Original article
Rapiti E, Tille JC, Fournier E, Saiji E, Weintraub D, Bouzourene H, Viassolo V, Bouchardy C, Chappuis PO, Benhamou S
Swiss Med Wkly. 2020;150:w20327

Family history is a known risk factor for breast cancer, but its prognostic value and the prognostic value of tumour characteristics in relation to family history has not been clearly established.

Actionability and scope should determine the extent of counselling for presymptomatic genetic testing

Zimmermann B, Starke G, Shaw D, Elger B, Koné I
Swiss Med Wkly. 2020;150:w20274

Patients considering undergoing presymptomatic genetic and genomic testing commonly receive prior genetic counselling. However, there is a need to discuss further why genetic counselling has such unique and high importance in many countries worldwide. This discussion will help to rationalise resource allocations within healthcare systems and improve patient communication in genetics and other fields.

Medical-ethical recommendations: preimplantation genetic testing PGT

Special article
Swiss Academy of Medical Sciences
Swiss Med Wkly. 2020;150:w20298

The recommendations of the Swiss Academy of Medical Sciences (SAMS) are designed to draw attention, from an ethical perspective, to important aspects of the PGT counselling and decision-making situation, and to promote ethical awareness in the performance of PGT. In addition, they discuss how, for example, surplus information should be managed.

HLA studies in the context of coronavirus outbreaks

Sanchez-Mazas A
Swiss Med Wkly. 2020;150:w20248

Little is known at the moment about specific immune mechanisms that would work against SARS-CoV-2, although such knowledge is expected to play a vital role. In this context, a particular focus has to be given to the human leucocyte antigen system that governs our adaptive immunity.

A review of HLA allele and SNP associations with highly prevalent infectious diseases in human populations

Review article: Biomedical intelligence
Sanchez-Mazas A
Swiss Med Wkly. 2020;150:w20214

This article reviews the associations that have been best documented between markers at classical HLA genes and six of the most prevalent infectious diseases, and discusses this in a population genetics and evolutionary perspective.

Prevalence of genetic susceptibility for breast and ovarian cancer in a non-cancer related study population: secondary germline findings from a Swiss single centre cohort

Original article
Kraemer D, Azzarello-Burri S, Steindl K, Boonsawat P, Zweier M, Dedes KJ, Joset P, Fink D, Rauch A
Swiss Med Wkly. 2019;149:w20092

Since the advent of high-throughput sequencing technologies, organised germline screening, independent of personal and family cancer history, has been frequently proposed. A critical prerequisite is knowledge of the expected carrier frequencies.

A new era of gene editing for the treatment of human diseases

Review article: Biomedical intelligence
KC M, Steer CJ
Swiss Med Wkly. 2019;149:w20021

Significant advances in the field of gene editing have not only provided new tools for genetic surgery, but have also heralded a new era of medicine, with possibilities never imagined even half a century ago.

Genetics and epigenetics of inflammatory bowel disease

Review article: Biomedical intelligence
Wawrzyniak M, Scharl M
Swiss Med Wkly. 2018;148:w14671

Current knowledge about genetic and epigenetic involvement in the pathogenesis of inflammatory bowel disease is poor. In addition to genetic alterations, the intestinal microbiota and environmental factors also play a critical role.

Verpassen Sie keinen Artikel!